Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 261

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury

Open access
Gaudin, Alice, Yemisci, Müge, Eroglu, Hakan, Lepetre-Mouelhi, Sinda, Turkoglu, Omer Faruk, Dönmez-Demir, Buket, Caban, Seçil, Sargon, Mustafa Fevzi, Garcia-Argote, Sébastien, Pieters, Grégory, Loreau, Olivier, Rousseau, Bernard, Tagit, Oya, Hildebrandt, Niko, Le Dantec, Yannick, Mougin, Julie, Valetti, Sabrina, Chacun, Hélène, Nicolas, Valérie, Desmaële, Didier, Andrieux, Karine, Capan, Yilmaz, Dalkara, Turgay, Couvreur, Patrick·2014·Nature Nanotechnology

Abstract

There is an urgent need to develop new therapeutic approaches for the treatment of severe neurological trauma, such as stroke and spinal cord injuries. However, many drugs with potential neuropharmacological activity, like adenosine, are inefficient upon systemic administration because of their fast metabolisation and rapid clearance from the bloodstream. Here, we show that the conjugation of adenosine to the lipid squalene and the subsequent formation of nanoassemblies allow a prolonged circulation of this nucleoside, to provide neuroprotection in mouse stroke and rat spinal cord injury models. The animals receiving systemic administration of squalenoyl adenosine nanoassemblies showed a significant improvement of their neurologic deficit score in the case of cerebral ischaemia, and an early motor recovery of the hindlimbs in the case of spinal cord injury. Moreover, in vitro and in vivo studies demonstrated that the nanoassemblies were able to extend adenosine circulation and its interaction with the neurovascular unit. This paper shows, for the first time, that a hydrophilic and rapidly metabolised molecule like adenosine may become pharmacologically efficient owing to a single conjugation with the lipid squalene.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nnano.2014.274

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 261

Metadata

Authors
Gaudin, A., Yemisci, M., Eroglu, H., Lepetre-Mouelhi, S., Turkoglu, O. F., Dönmez-Demir, B., Caban, S., Sargon, M. F., Garcia-Argote, S., Pieters, G., Loreau, O., Rousseau, B., Tagit, O., Hildebrandt, N., Le Dantec, Y., Mougin, J., Valetti, S., Chacun, H., Nicolas, V., Desmaële, D., Andrieux, K., Capan, Y., Dalkara, T., & Couvreur, P.
Venue
Nature Nanotechnology
Published
2014-11-24
Volume
9
Issue
12
Pages
1054-1062
ISSN
  • 1748-3387 (ISSN-L)
  • 1748-3395
OpenAlex
W2114611409
Cited by
261
References
41
FWCI
6.06
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury. https://app.cochat.ai/papers/10.1038/nnano.2014.274
The paper
Gaudin, A., Yemisci, M., Eroglu, H., Lepetre-Mouelhi, S., Turkoglu, O. F., Dönmez-Demir, B., Caban, S., Sargon, M. F., Garcia-Argote, S., Pieters, G., Loreau, O., Rousseau, B., Tagit, O., Hildebrandt, N., Le Dantec, Y., Mougin, J., Valetti, S., Chacun, H., Nicolas, V., . . . Couvreur, P. (2014). Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury. Nature Nanotechnology. https://doi.org/10.1038/nnano.2014.274

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.